Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Conditions:   Pancreas Cancer;   Pancreatic Cancer;   Cancer of the Pancreas Interventions:   Biological: Neoantigen Peptide Vaccine;   Drug: Poly ICLC;   Procedure: Blood for immune monitoring Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH);   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials